These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4840669)

  • 1. [Polymorphism of 5-allyl-5-(beta-hydroxypropyl)-barbituric acid].
    Grabowska I; Kaliszan R; Zoga P
    Acta Pol Pharm; 1974; 31(2):189-93. PubMed ID: 4840669
    [No Abstract]   [Full Text] [Related]  

  • 2. Resolution of optical isomers of 5-allyl-5-(beta-hydroxypropyl)-barbituric acid (Ipronal, Axeen) and their pharmacological activity.
    Bobranski B; Wilimowski M; Barczynska J; Seniuta R; Sedzimirska B; Witkowska M
    Arch Immunol Ther Exp (Warsz); 1973; 21(2):299-308. PubMed ID: 4147382
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of 5-allilo-5-(2'-hydroxypropyl)-barbituric acid in decomposed solutions.
    Grabowska I; Kaliszan R; Zoga P
    Acta Pol Pharm; 1972; 29(6):585-90. PubMed ID: 4670134
    [No Abstract]   [Full Text] [Related]  

  • 4. [Stability of 5-allyl-5-(2'-hydroxypropyl)-barbituric acid solutions].
    Grabowska I; Kaliszan R; Zoga P
    Acta Pol Pharm; 1973; 30(2):173-7. PubMed ID: 4703974
    [No Abstract]   [Full Text] [Related]  

  • 5. INVESTIGATIONS ON THE MECHANISM OF THE DEGRADATION OF 5-ALLYL-5-(BETA-HYDROXYPROPYL)-BARBITURIC ACID IN THE ORGANISM. METABOLISM OF 1-METHYL-5-ALLYL-5-(BETA-HYDROXYPROPYL)-BARBITURIC ACIDS IN THE ORGANISM OF RABBITS.
    BOBRANSKI B; KONIECZNY M; SYPER L
    Arch Immunol Ther Exp (Warsz); 1962; 10():811-7. PubMed ID: 14054135
    [No Abstract]   [Full Text] [Related]  

  • 6. IR analysis of crystalline samples of some urea derivatives.
    Kaliszan R; Halkiewicz J
    Pol J Pharmacol Pharm; 1975; 27(5):579-87. PubMed ID: 241982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the reactions of barbituric acid derivatives. I. Synthesis of 5-allyl-5-(beta-aminopropyl)-barbituric acid.
    Konieczny M
    Arch Immunol Ther Exp (Warsz); 1967; 15(6):920-35. PubMed ID: 5586113
    [No Abstract]   [Full Text] [Related]  

  • 8. On 5-(1',2'-dimethylpropyl)-5-(2'-hydroxypropyl)-barbituric acid.
    Bobrański B; Pomorski J
    Arch Immunol Ther Exp (Warsz); 1967; 15(5):751-9. PubMed ID: 5595076
    [No Abstract]   [Full Text] [Related]  

  • 9. New isomerization reactions of barbituric acid derivatives and allied compounds.
    Bobrański B
    Farmaco Sci; 1972 May; 27(5):429-44. PubMed ID: 4554440
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the Ritter reaction. I. Synthesis of 3-/5-barbituryl/-propanesulfonic acids with anti-inflammatory activity.
    Radzicka A; Konieczny M
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):421-32. PubMed ID: 7184491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and mechanism of decomposition of some derivatives of 5-allylbarbituric acid. Part V. The course of hydrolysis of 5 allyl-5-(2'-hydroxypropyl)barbituric acid.
    Hermann T; Mokrosz J; Bojarski J
    Pol J Pharmacol Pharm; 1980; 32(5):807-13. PubMed ID: 6115373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic investigations of proxibarbal [5-allyl-5-(2-hydroxypropyl)barbituric acid] in vitro.
    Frochaux-Zeidler EL; Testa B
    Pharm Acta Helv; 1980; 55(3):79-82. PubMed ID: 6104818
    [No Abstract]   [Full Text] [Related]  

  • 13. [Solubility pattern of 2 crystallization modifications of 2-benzosulfonamido-5-(beta-hydroxyethoxy-)pyrimidines].
    Köhler HJ; Speiser P; Soliva M
    Pharm Acta Helv; 1975; 50(1-2):17-24. PubMed ID: 1114157
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on reactions of barbituric acid derivatives. II. Stereoisomers of 1-methyl-5-allyl-5-(2'-aminopropyl)-barbituric acid and related compounds.
    Konieczny M
    Arch Immunol Ther Exp (Warsz); 1968; 16(5):837-49. PubMed ID: 5709633
    [No Abstract]   [Full Text] [Related]  

  • 15. Spiro-annulation of barbituric acid derivatives and its analogs by ring-closing metathesis reaction.
    Kotha S; Deb AC; Kumar RV
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1039-43. PubMed ID: 15686908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barbiturates--structure versus RIA reactivity.
    Budd RD; Yang FC; Utley KO
    Clin Toxicol; 1981 Mar; 18(3):317-52. PubMed ID: 7237963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of acyloxyalkylbarbiturates as potential long-acting central nervous system depressants.
    Smissman EE; Robinson RA; Buckwalter MA
    J Med Chem; 1971 Sep; 14(9):853-5. PubMed ID: 5140013
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel isothiourea derivatives as potent neuroprotectors and cognition enhancers: synthesis, biological and physicochemical properties.
    Perlovich GL; Proshin AN; Volkova TV; Kurkov SV; Grigoriev VV; Petrova LN; Bachurin SO
    J Med Chem; 2009 Apr; 52(7):1845-52. PubMed ID: 19338354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of barbituric acid derivatives by x-ray powder photograms. VIII. 5-Allyl-5-ethylbarbituric acid and the system, 5-allyl-5-ethyl-diallyl-barbituric acid].
    HEIZ R; JERSLEV B
    Dan Tidsskr Farm; 1954 Jan; 28(1):11-8. PubMed ID: 13150792
    [No Abstract]   [Full Text] [Related]  

  • 20. The polymorphism of indomethacine. New modifications, their melting behavior and solubility.
    Borka L
    Acta Pharm Suec; 1974 Jun; 11(3):295-303. PubMed ID: 4839739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.